Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study

Clinical trial NCT01101555 · COMPLETED

Trial details

NCT number: NCT01101555
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2010-05-12
Primary completion: 2011-09-16
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.